[1]
“Nutritional interventions associated with the use of Glucagon-Like Peptide-1 receptor agonists in the treatment of obesity”, Acervo Saúde, vol. 26, no. 7, p. e23909, Jul. 2026, doi: 10.25248/reas.e23909.2026.